SUMMARY Labetalol was used to treat systemic hypertension (systolic blood pressure above 150 mmHg) in 11 patients with acute myocardial infarction; its haemodynamic effects and tolerance were studied.
Systemic hypertension is frequent in the acute stage of myocardial infarction' and is associated with a higher incidence of complications.24 Labetalol which combines alpha and beta adrenoceptor blockade seems to be an effective drug in managing this type of hypertension.5 6 This study was designed to evaluate the haemodynamic changes and the clinical response after intravenous administration of labetalol to such patients.
Patients and methods
Eleven patients were studied (10 men and one woman), all of whom were less than 70 years of age.
Criteria for inclusion were: (1) acute (less than 48 hours) infarction (that is severe chest pain, appearance of new Q waves and/or abnormal levels of MB Accepted for publication 3 February 1983 creatinine kinase); (2) systemic hypertension (systolic value greater than 150 mmHg) persisting over six hours in spite of adequate sedation and control of chest pain; (3) normal sinus rhythm; and (4) cardiac index greater than 2*4 1/min per M2.
Patients with clinical signs of severe heart failure or with second or third degree atrioventricular block were excluded, as were patients previously treated with digitalis, beta blockers, or vasodilators. RHYTHM The optimal infusion rate of labetalol determined from the haemodynamic response was within the range of 0.8 to 4.8 mg/min (mean 2-3 mg/min); the drug was generally effective within the first minutes of the infusion.
HAEMODYNAMIC RESULTS
Mean values are given in Table 2 and illustrated in Fig. 1 The values given here are those observed after one hour of infusion. Systemic pressures (systolic, diastolic, and mean) and total systemic resistance ( Fig. 1) were significantly decreased during infusion at the optimal rate. The decrease in total systemic resistance was highly significant (17-7 to 14 IU; p<0001). Heart rate was significantly lowered during the infusion (94 to 81 beats/min, p<0 001); cardiac index ( Fig. 2 ) was significantly reduced (3.1 to 2-7 1/min per M2; p<0.001) but the stroke index was not significantly changed. Left ventricular stroke work index was also significantly decreased (43 to 29-8 g.n/m2; p<0-001) during labetalol administration.
Pulmonary artery pressures (systolic, diastolic, and mean) and pulmonary wedge pressure were slightly decreased ( Fig. 3 ), but not significantly; the right atrial pressure was almost unchanged. The double product (Fig. 4) was greatly reduced throughout the period of labetalol infusion (16 497 to 8598 mmHgx beats/min).
As shown on Fig. 1 to 4 , comparable changes are already observed 15 and 30 minutes after the infusion.
COMPARISON BETWEEN HAEMODYNAMIC STATUS OBSERVED AT END OF LABETALOL INFUSION AND VALUES OBSERVED ONE HOUR AND FOUR HOURS AFTER INFUSION WAS STOPPED
There was a significant increase in systemic blood pressure (systolic, diastolic, and mean) after the infu- Heart rate, cardiac index, stroke index, and left ventricular stroke work index were not significantly altered. Pulmonary pressures including wedge pressure and atrial pressure remained unchanged. Double product increased slightly after one hour, and significantly after four hours (8598 to 12 280 mmHgxbeats/min).
INDIVIDUAL EVOLUTION OF LEFT VENTRICULAR FUNCTION
In Fig. 5 , the pulmonary wedge pressure was plotted against the cardiac index showing the individual evolution of the left ventricular function between the control values and those observed after one hour of infusion with the optimal dose. The cardiac index decreased in all but two cases; this fall was particularly important in one case (from 2-5 to 17 1/min per m2), most probably related to the pronounced decrease in pulmonary wedge pressure (from 21 to 5 mmHg). The curves of the six patients who initially had raised pulmonary wedge pressures greater than 15 mmHg shifted to the left; this beneficial effect on preload may be favourable in patients with mild left heart failure. good condition: one died from refractory ventricular fibrillation secondary to recurring acute myocardial infarction on day 5, the other from cardiogenic shock on day 3 after completion of the labetalol treatment.
Discussion
-----I Systemic hypertension is frequent during the first hours of acute myocardial infarction; blood pressure normalises spontaneously in most cases, however, during the first six hours as the pain is relieved and the patient becomes relaxed.' In some cases blood pressure remains high; many consider it should be treated rapidly because it is a major factor of myocardial oxygen demands and is potentially deleterious.24
Vasodilators are effective in reducing the high blood >-~Jj -^pressure but they generally increase the heart rate,
..I which is unfavourable.9-"1 Beta blockers decrease blood pressure and heart rate but they increase systemic resistance when they are injected; furthermore, beta2 blockers may promote constriction of the coronary arteries which would also be deleterious. 12 r Labetalol which combines alpha and beta 4 -1-----I adrenoreceptor blockade should prevent any vasoconstrictive effect associated with pure beta blockadel3 F.,,,, . 
